Epoch Biodesign raised $18.3M in Series A funding to scale up production of their plastic-eating enzymes.
Amount Raised
$18.3 Million
Round Type
Series A
LondonBiotechnologyConsumer GoodsHealth CareInvestors
Description
Epoch Biodesign, a U.K. startup, has secured $18.3 million in Series A funding to scale its production of enzymes that break down plastic waste. Founded in 2019, the company aims to transfer its biorecycling process from labs to a production facility capable of processing 150 tonnes of waste annually.
Quick answer
Epoch Biodesign raised $18.3 Million in a Series A round, dated March 5, 2025. Investors: Kompas, Day One Ventures, Kibo Invest, Happiness Capital, Lowercarbon Capital and Extantia. Epoch Biodesign is based in London, England, United Kingdom.
- How much did Epoch Biodesign raise?
- Epoch Biodesign raised $18.3 Million in a Series A round on March 5, 2025.
- Who invested in Epoch Biodesign?
- Kompas, Day One Ventures, Kibo Invest, Happiness Capital, Lowercarbon Capital and Extantia are named as investors in this round.
- What does Epoch Biodesign do?
- Epoch’s biorecycling platform unlocks circularity for the toughest-to-recycle materials.
- Where is Epoch Biodesign based and how big is it?
- Epoch Biodesign is based in London, England, United Kingdom. Fundz records about 33 employees.
- Who are the decision-makers at Epoch Biodesign?
- Fundz holds 1 contact at Epoch Biodesign. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Consumer Goods and Biotechnology around the same time
Companies in the same sectors as Epoch Biodesign that raised within 45 days of this round, from Fundz verified event records.
- AMT Medical raised $25M (Series B) on April 17, 2025.
- RISA Labs raised $3.5M (Seed) on April 17, 2025.
- Lexington Medical raised an undisclosed amount (Corporate Round) on April 17, 2025.
- Pathos AI raised $283M on April 17, 2025.
- Skin Analytics raised $20M (Series B) on April 16, 2025.
- Medcura raised $29M on April 16, 2025.
Who to call at Epoch Biodesign, and when
A new round usually means Epoch Biodesign is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Epoch Biodesign raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Epoch Biodesign, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Epoch Biodesign. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Epoch Biodesign raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansEpoch Biodesign raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.